LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 3 of total 3

Search options

  1. Article ; Online: Targeted Protein Degradation through Recruitment of the CUL4 Complex Adaptor Protein DDB1.

    Meyers, Margot / Cismoski, Sabine / Panidapu, Anoohya / Chie-Leon, Barbara / Nomura, Daniel K

    ACS chemical biology

    2024  Volume 19, Issue 1, Page(s) 58–68

    Abstract: Targeted protein degradation has arisen as a powerful therapeutic modality for eliminating proteins. Thus far, most heterobifunctional proteolysis targeting chimeras (PROTACs) have utilized recruiters against substrate receptors of Cullin RING E3 ... ...

    Abstract Targeted protein degradation has arisen as a powerful therapeutic modality for eliminating proteins. Thus far, most heterobifunctional proteolysis targeting chimeras (PROTACs) have utilized recruiters against substrate receptors of Cullin RING E3 ubiquitin ligases, such as cereblon and VHL. However, previous studies have surprisingly uncovered molecular glue degraders that exploit a CUL4 adaptor protein DDB1 to degrade neosubstrate proteins. Here, we sought to investigate whether DDB1 recruiters can be discovered that can be exploited for PROTAC applications. We utilized activity-based protein profiling and cysteine chemoproteomic screening to identify a covalent recruiter that targets C173 on DDB1 and exploited this recruiter to develop PROTACs against BRD4 and androgen receptor (AR). We demonstrated that the BRD4 PROTAC results in selective degradation of the short BRD4 isoform over the long isoform in a proteasome, NEDDylation, and DDB1-dependent manner. We also demonstrated degradation of AR with the AR PROTAC in prostate cancer cells. Our study demonstrated that covalent chemoproteomic approaches can be used to discover recruiters against Cullin RING adapter proteins and that these recruiters can be used for PROTAC applications to degrade neo-substrates.
    MeSH term(s) Proteolysis ; Cullin Proteins/metabolism ; Transcription Factors/metabolism ; Nuclear Proteins/metabolism ; Ubiquitin-Protein Ligases/metabolism ; Adaptor Proteins, Signal Transducing/metabolism ; Proteasome Endopeptidase Complex/metabolism ; Protein Isoforms/metabolism
    Chemical Substances Cullin Proteins ; Transcription Factors ; Nuclear Proteins ; Ubiquitin-Protein Ligases (EC 2.3.2.27) ; Adaptor Proteins, Signal Transducing ; Proteasome Endopeptidase Complex (EC 3.4.25.1) ; Protein Isoforms
    Language English
    Publishing date 2024-01-08
    Publishing country United States
    Document type Journal Article
    ISSN 1554-8937
    ISSN (online) 1554-8937
    DOI 10.1021/acschembio.3c00487
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Targeted Protein Degradation through Recruitment of the CUL4A Complex Adaptor Protein DDB1.

    Meyers, Margot / Cismoski, Sabine / Panidapu, Anoohya / Chie-Leon, Barbara / Nomura, Daniel K

    bioRxiv : the preprint server for biology

    2023  

    Abstract: Targeted protein degradation has arisen as a powerful therapeutic modality for eliminating proteins. Thus far, most heterobifunctional Proteolysis Targeting Chimeras (PROTACs) have utilized recruiters against substrate receptors of Cullin RING E3 ... ...

    Abstract Targeted protein degradation has arisen as a powerful therapeutic modality for eliminating proteins. Thus far, most heterobifunctional Proteolysis Targeting Chimeras (PROTACs) have utilized recruiters against substrate receptors of Cullin RING E3 ubiquitin ligases, such as cereblon and VHL. However, previous studies have surprisingly uncovered molecular glue degraders that exploit a CUL4A adaptor protein DDB1 to degrade neosubstrate proteins. Here, we sought to investigate whether DDB1 recruiters can be discovered that can be exploited for PROTAC applications. We utilized activity-based protein profiling and cysteine chemoproteomic screening to identify a covalent recruiter that targets C173 on DDB1 and exploited this recruiter to develop PROTACs against BRD4 and androgen receptor (AR). We demonstrated that the BRD4 PROTAC results in selective degradation of the short BRD4 isoform over the long isoform in a proteasome, NEDDylation, and DDB1-dependent manner. We also demonstrated degradation of AR with the AR PROTAC in prostate cancer cells. Our study demonstrated that covalent chemoproteomic approaches can be used to discover recruiters against Cullin RING adapter proteins and that these recruiters can be used for PROTAC applications to degrade neo-substrates.
    Language English
    Publishing date 2023-08-12
    Publishing country United States
    Document type Preprint
    DOI 10.1101/2023.08.11.553046
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Deubiquitinase-targeting chimeras for targeted protein stabilization.

    Henning, Nathaniel J / Boike, Lydia / Spradlin, Jessica N / Ward, Carl C / Liu, Gang / Zhang, Erika / Belcher, Bridget P / Brittain, Scott M / Hesse, Matthew J / Dovala, Dustin / McGregor, Lynn M / Valdez Misiolek, Rachel / Plasschaert, Lindsey W / Rowlands, David J / Wang, Feng / Frank, Andreas O / Fuller, Daniel / Estes, Abigail R / Randal, Katelyn L /
    Panidapu, Anoohya / McKenna, Jeffrey M / Tallarico, John A / Schirle, Markus / Nomura, Daniel K

    Nature chemical biology

    2022  Volume 18, Issue 4, Page(s) 412–421

    Abstract: Many diseases are driven by proteins that are aberrantly ubiquitinated and degraded. These diseases would be therapeutically benefited by targeted protein stabilization (TPS). Here we present deubiquitinase-targeting chimeras (DUBTACs), ... ...

    Abstract Many diseases are driven by proteins that are aberrantly ubiquitinated and degraded. These diseases would be therapeutically benefited by targeted protein stabilization (TPS). Here we present deubiquitinase-targeting chimeras (DUBTACs), heterobifunctional small molecules consisting of a deubiquitinase recruiter linked to a protein-targeting ligand, to stabilize the levels of specific proteins degraded in a ubiquitin-dependent manner. Using chemoproteomic approaches, we discovered the covalent ligand EN523 that targets a non-catalytic allosteric cysteine C23 in the K48-ubiquitin-specific deubiquitinase OTUB1. We showed that a DUBTAC consisting of our EN523 OTUB1 recruiter linked to lumacaftor, a drug used to treat cystic fibrosis that binds ΔF508-cystic fibrosis transmembrane conductance regulator (CFTR), robustly stabilized ΔF508-CFTR protein levels, leading to improved chloride channel conductance in human cystic fibrosis bronchial epithelial cells. We also demonstrated stabilization of the tumor suppressor kinase WEE1 in hepatoma cells. Our study showcases covalent chemoproteomic approaches to develop new induced proximity-based therapeutic modalities and introduces the DUBTAC platform for TPS.
    MeSH term(s) Chimera/metabolism ; Cystic Fibrosis/drug therapy ; Cystic Fibrosis/metabolism ; Cystic Fibrosis Transmembrane Conductance Regulator/genetics ; Cystic Fibrosis Transmembrane Conductance Regulator/metabolism ; Deubiquitinating Enzymes/metabolism ; Deubiquitinating Enzymes/therapeutic use ; Humans ; Ligands ; Ubiquitin/metabolism
    Chemical Substances Ligands ; Ubiquitin ; Cystic Fibrosis Transmembrane Conductance Regulator (126880-72-6) ; Deubiquitinating Enzymes (EC 3.4.19.12)
    Language English
    Publishing date 2022-02-24
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, Non-P.H.S.
    ZDB-ID 2202962-X
    ISSN 1552-4469 ; 1552-4450
    ISSN (online) 1552-4469
    ISSN 1552-4450
    DOI 10.1038/s41589-022-00971-2
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top